{
    "title": "Drugmaker Teva may pay as much as $3.6 billion in U.S. opioid settlement",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10493869/Teva-Pharm-Q4-profit-rises-sees-growth-key-drugs.html",
    "date": "2022-02-09",
    "keywords": [
        "settlement",
        "teva",
        "drug",
        "revenue",
        "cash",
        "drugmaker",
        "schultz",
        "year",
        "treatment",
        "share",
        "scheer",
        "wednesday",
        "medicine",
        "johnson",
        "portion",
        "texas",
        "deal",
        "time",
        "austedo",
        "quarter",
        "reporting",
        "jerusalem",
        "week",
        "executive",
        "k\u00e5re",
        "spread",
        "model",
        "one",
        "need",
        "substance",
        "abuse",
        "profit",
        "beat",
        "breakthrough",
        "framework",
        "state",
        "addiction",
        "value",
        "scepticism",
        "extrapolation",
        "entity",
        "lawsuit",
        "clearcut",
        "geller",
        "lead",
        "attorney",
        "amp",
        "dowd",
        "covid19",
        "product",
        "company",
        "decline",
        "refinitiv",
        "forecast",
        "ajovy",
        "europe",
        "growth",
        "sclerosis",
        "copaxone",
        "competition",
        "approval",
        "mid2022",
        "risperidone",
        "schizophrenia",
        "doubledigit",
        "market",
        "version",
        "raymond",
        "boston",
        "editing",
        "jason",
        "baum",
        "aurora",
        "ellis"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}